Discovery of the Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19
临床候选药物S-892216的发现：第二代SARS-CoV-2 3CL蛋白酶抑制剂，用于治疗COVID-19
期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.5c00754
Unoh, Yuto; Hirai, Keiichiro; Uehara, Shota; Kawashima, Sho; Nobori, Haruaki; Sato, Jun; Shibayama, Hiromitsu; Hori, Akihiro; Nakahara, Kenji; Kurahashi, Kana; Takamatsu, Masayuki; Yamamoto, Shiho; Zhang, Qianhui; Tanimura, Miki; Dodo, Reiko; Maruyama, Yuki; Sawa, Hirofumi; Watari, Ryosuke; Miyano, Tetsuya; Kato, Teruhisa; Sato, Takafumi; Tachibana, Yuki
